HK1105808A1 - Pharmaceutical formulations for parenteral administration comprising epothilone - Google Patents

Pharmaceutical formulations for parenteral administration comprising epothilone

Info

Publication number
HK1105808A1
HK1105808A1 HK07113893.4A HK07113893A HK1105808A1 HK 1105808 A1 HK1105808 A1 HK 1105808A1 HK 07113893 A HK07113893 A HK 07113893A HK 1105808 A1 HK1105808 A1 HK 1105808A1
Authority
HK
Hong Kong
Prior art keywords
epothilone
parenteral administration
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
HK07113893.4A
Inventor
Peter Van Hoogevest
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9802451.6A external-priority patent/GB9802451D0/en
Application filed by Novartis Ag filed Critical Novartis Ag
Priority claimed from HK01103518.6A external-priority patent/HK1033809A1/en
Publication of HK1105808A1 publication Critical patent/HK1105808A1/en

Links

HK07113893.4A 1998-02-05 2001-05-22 Pharmaceutical formulations for parenteral administration comprising epothilone HK1105808A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9802451.6A GB9802451D0 (en) 1998-02-05 1998-02-05 Organic compounds
HK01103518.6A HK1033809A1 (en) 1998-02-05 2001-05-22 Pharmaceutical formulation containing epothilone

Publications (1)

Publication Number Publication Date
HK1105808A1 true HK1105808A1 (en) 2008-02-22

Family

ID=41076770

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07113893.4A HK1105808A1 (en) 1998-02-05 2001-05-22 Pharmaceutical formulations for parenteral administration comprising epothilone

Country Status (1)

Country Link
HK (1) HK1105808A1 (en)

Similar Documents

Publication Publication Date Title
SG79255A1 (en) Pharmaceutical formulations
CZ20011186A3 (en) Stabilized pharmaceutical preparation
IL147756A0 (en) Preserved pharmaceutical formulations
HK1045804A1 (en) Improved pharmaceutical formulations comprising ritonavir
AU6715600A (en) Pharmaceutical formulations
SG63824A1 (en) Rapamycin formulations for oral administration
HK1045102A1 (en) Pharmaceutical formulations
HUP0003341A3 (en) Rapamycin formulations for oral administration
AU1385801A (en) Pharmaceutical formulations
GB9818927D0 (en) Pharmaceutical formulation
GB9822333D0 (en) Pharmaceutical formulation
GB9930578D0 (en) Pharmaceutical formulations
GB9906126D0 (en) Pharmaceutical formulations
HK1105808A1 (en) Pharmaceutical formulations for parenteral administration comprising epothilone
GB9817470D0 (en) Pharmaceutical formulation
GB9802617D0 (en) Pharmaceutical formulation
GB9905983D0 (en) Pharmaceutical formulations
GB9903177D0 (en) Pharmaceutical formulations
GB9911826D0 (en) Pharmaceutical formulations
GB9805931D0 (en) Pharmaceutical formulations
GB9817429D0 (en) Pharmaceutical formulations
GB9820837D0 (en) Pharmaceutical formulations
GB9816558D0 (en) Pharmaceutical formulations
GB9807556D0 (en) Pharmaceutical formulations
GB9823192D0 (en) Pharmaceutical formulations

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150203